AI assistant
Sending…
SOLIGENIX, INC. — Director's Dealing 2019
Dec 13, 2019
35119_dirs_2019-12-13_edc7d7ac-fe05-4338-9a04-8ab5f8ff88d3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2019-12-12
Reporting Person: Donini Oreola (SVP and CSO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-12-12 | Option (Right to Buy) | $1.24 | A | 60000 | Acquired | 2029-12-11 | Common Stock (60000) | Direct |
Footnotes
F1: The stock option vested immediately as to 15,000 shares and vests as to the remainder at a rate of 3,750 of the shares on each three (3) month anniversary of December 12, 2019.
More from SOLIGENIX, INC.
Regulatory Filings
2026
May 28
Capital/Financing Update
2026
May 28
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Capital/Financing Update
2026
May 8
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3